Trends in utilization of advanced therapies in patients with inflammatory bowel diseases in the USA, 2021-2025
Contemporary trends in advanced therapy utilization in patients with IBD suggest an increased utilization of upadacitinib and anti-interleukins, accompanied by a decline in use of TNF antagonists in the USA.
Authors
- Shane W. Goodwin (ORCID: https://orcid.org/0009-0005-5820-078X)
- Aakash Desai (ORCID: https://orcid.org/0000-0002-2943-3817)
- Gursimran Kochhar (ORCID: https://orcid.org/0000-0002-0597-2760)
- Vipul Jairath (ORCID: https://orcid.org/0000-0003-1590-0338)
- Siddharth Singh
Institutions
- Western University (CA)
- Allegheny Health Network (US)
- London Health Sciences Centre (CA)
- Mayo Clinic in Arizona (US)
- Drexel University (US)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf186
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00